Close Menu

Miller School of Medicine

BOSTON (GenomeWeb Daily News) – While panelists at a session at the American Society of Human Genetics annual meeting on Saturday said that the public is cautiously interested in including whole-exome or whole-genome sequencing as part of newborn screening efforts, there are concerns regarding pr

This article has been updated to reflect that the clinical sequencing services will be integrated into existing CLIA laboratories.

Exiqon said last week that it has established a center of excellence at the Oncogenomics Core Facility at the Sylvester Comprehensive Care Center at the University of Miami Miller School of Medicine.

The gift from the John P. Hussman Foundation will support autism genomics studies.

The school will use the company's cancer diagnostic microarray to study ethnic differences in breast cancer.

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.